Chimeric canine anti-CD20 antibody
Abstract:
The disclosure relates to caninized chimeric anti-CD20 antibodies to the canine protein CD20 and methods of use to treat certain disorders such as non-Hodgkins B-cell lymphoma in dogs.
Information query
Patent Agency Ranking
0/0